Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography

[1]  Carol C Wu,et al.  Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  Luca Errico,et al.  Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  Peter R. Luijten,et al.  Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology , 2008, European Radiology.

[4]  H. Zhang,et al.  Mediastinal lymph nodes staging by 18F-FDG PET/CT for early-stage non-small cell lung cancer: A multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Boiselle,et al.  Mediastinal Lymph Nodes in Patients With Non-small Cell Lung Cancer: Preliminary Experience With Diffusion-weighted MR Imaging , 2008, Journal of thoracic imaging.

[6]  Wei Chen,et al.  Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? , 2010, Magnetic resonance imaging.

[7]  M. Muers,et al.  The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. , 2009, Lung cancer.

[8]  M. Matoba,et al.  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. , 2007, Radiology.

[9]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[10]  S. Reske,et al.  Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. , 2012, European journal of radiology.

[11]  S. Matsumoto,et al.  Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy , 2009, Journal of magnetic resonance imaging : JMRI.

[12]  Douglas C McCrory,et al.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence. , 2003, Chest.

[13]  Kazuhiro Katahira,et al.  Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? , 2009, The Journal of thoracic and cardiovascular surgery.

[14]  T. Takahara,et al.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.

[15]  Y. Kitazume,et al.  Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? , 2008, AJR. American journal of roentgenology.

[16]  M. Matoba,et al.  Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. , 2011, The Annals of thoracic surgery.

[17]  S. Matsumoto,et al.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.

[18]  Y. Liu,et al.  Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions , 2010, European Radiology.

[19]  T. Barth,et al.  Comparison of Clinical and Surgical-Pathological Staging in IIIA Non-Small Cell Lung Cancer Patients , 2011, Annals of Surgical Oncology.

[20]  P. Koşucu,et al.  Mediastinal lymph nodes: Assessment with diffusion‐weighted MR imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[21]  W. Nishio,et al.  N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. , 2011, Radiology.

[22]  Hisao Asamura,et al.  The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  K. Chida,et al.  Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.

[24]  S. Shiraishi,et al.  Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. , 2008, The Journal of thoracic and cardiovascular surgery.

[25]  Yoshitsugu Matsumoto,et al.  In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. , 2009, Oncology reports.

[26]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[27]  P. Valk,et al.  Factors associated with false-positive staging of lung cancer by positron emission tomography. , 2000, The Annals of thoracic surgery.

[28]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[29]  H. Shirato,et al.  Metastases in Mediastinal and Hilar Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Quantitative Assessment With Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient , 2010, Journal of computer assisted tomography.

[30]  S. Shiraishi,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Jinming Yu,et al.  Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  V. Muse,et al.  Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.